Prediction: Lilly Will Trade at $1,200 by Year-End
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Review which Dividend Aristocrats ETF has the highest management fee and how it affects net performance.
28,021 articlesInvestors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
In Buffett's final chapters as Berkshire's CEO, one move stood out: selling a stock that helped build his fortune. Th...
A rare stock market signal has flashed again, marking the ninth occurrence since 1950. Goldman Sachs says the readout...
Bitdeer’s May 2026 update shows a spike in BTC mined alongside a steep drop in BTC held, underscoring the tension bet...
Strategy Inc. escalated its Bitcoin purchases with a $1.3 billion bet funded largely by new common shares and STRC pr...
AI infrastructure bets push a trillion-dollar spending agenda, yet water-use concerns from almond farming and local o...
Intel stock has surged 250% this year, turning a familiar name into a headline player. This article breaks down what ...
C3.AI has faced a rough run, leaving investors wondering if a comeback is possible. This article breaks down the fact...
As AI fuels energy needs, NuScale’s small modular reactors offer a faster, scalable path to cleaner power. This guide...
Meta's plan to price AR glasses at $300 could be a turning point for investors. This article breaks down the potentia...
As Walmart names John Furner CEO, the retail giant leans on AI and a family-led leadership creed to reshape operation...
Greg Abel, Warren Buffett's successor, steered a careful set of portfolio moves in the first quarter. This article br...